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Abstract 
A tryptophan to arginine substitution (TGG↔CGG) in codon 64 (Trp 64 Arg) of β3-adrenergic receptor is 
thought to be important for binding of noradrenaline and G proteins with β3-adrenergic receptor in adipose cells. 
β3-adrenergic receptor polymorphism may lead to a decrease in thermogenesis and lipolysis in adipose tissue. 
Therefore, an impairment of β3-adrenergic receptor function may lead to obesity and insulin resistance. The 
present study was designed to estimate prevalence and association of β3-adrenergic receptor gene T↔C (Trp 64 
Arg) SNP in insulin resistance type 2 diabetic patients in Iraq. To achieve this aim, 103 of type 2 diabetic 
patients and 57 apparently healthy control group were subjected to the study. The results of present study show 
that the heterozygous genotype (TC) of  β3-adrenergic receptor gene T↔C (Trp 64 Arg) SNP was significantly 
increased (OR=4.12, CI 95% 1.14-15.86, P < 0.05) the risk of type 2 diabetes mellitus four folds with respect to 
those of the wild genotype (TT). Also, the results revealed that significant increase (P < 0.05) in fasting insulin, 
HOMA, BMI and significant decrease (P < 0.05) in HDL-cholesterol of heterozygous genotype (TC) when 
compared with wild genotype (TT). Also, there are no significant differences in other clinical characteristics 
between wild genotype (TT) and heterozygous genotype (TC). The study concluded that β3-adrenergic receptor 
gene T↔C (Trp 64 Arg) SNP are associated and involved in the pathogenesis of insulin resistant type 2 diabetes 
mellitus.  
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1. Introduction 
Type 2 diabetes mellitus is a non autoimmune, heterogeneous and polygenic metabolic diseases characterized by 
hyperglycemia, resulting from impairment of insulin secretion and/or action (1). Insulin resistance, the reduction 
of insulin sensitivity by insulin responsive tissues lead to decrease the ability of insulin to inhibit the production 
of glucose by the liver and decrease peripheral glucose utilization. Consequently, blood glucose level would be 
rise in insulin resistance and increase the secretion of insulin to overcome insulin resistance (2). 
Obesity is the main risk cause for type 2 diabetes mellitus and it coupled with glucose intolerance, 
particularly when obesity is centrally distributed. Although the environmental factors participate in the obesity, 
the genetic are also affect on both total adiposity and body fat distribution. Several studies suggested that a low 
rate of energy expenditure and reduced rates of fat oxidation may contribute to obesity       (3, 4, 5). The β3-
adrenergic receptor is expressed in visceral fat in humans and it is responsible for increase the lipolysis and the 
delivery of free fatty acid into the portal vein (6). An increase in visceral fat mass, in turn, correlates with insulin 
resistance in skeletal muscle. There is an evidence that molecular abnormalities in the β3-adrenergic receptor 
may lead to obesity and type 2 diabetes mellitus (7). 
 
1.1. Aims of the study                 
The aims of this study to estimate prevalence and association of β3-adrenergic receptor gene T↔C (Trp 64 Arg) 
SNP in insulin resistant type 2 diabetic patients in Iraqi population.  
 
2. Materials and Methods 
2.1. Materials 
2.1.1. Subjects 
The study included type 2 diabetic patients and control group. All samples were collected from February 2013 
till May 2013. The work was carried out in the biochemistry department laboratory in College of 
Medicine/University of Kufa. The study was performed on 103 of type 2 diabetic patients and 57 apparently 
healthy control group. Any subject suffered from problems such as, renal dysfunction, heart diseases, 
hypertension, patient on insulin therapy and drug dependency such as glucocorticoid were excluded from the 
current study. 
2.1.2. Blood Sampling 
Five milliliters of blood was taken from all subjects by vein puncture in fasting status and the blood was divided 
into two parts, the first part include three milliliters of blood placed in plain tube for estimation of insulin, 
glucose, total cholesterol, HDL-cholesterol, TGs, VLDL-cholesterol and LDL-cholesterol concentrations. The 
second part for gene analysis includes two milliliters of blood will be collected in EDTA containing tube. 
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2.2. Methods 
Serum glucose, total cholesterol, triglycerides (TGs) and HDL-cholesterol concentration determined by 
spectrophotometric methods. While serum insulin concentration determined by enzyme linked immunosorbant 
assay (ELISA) method. Insulin resistance was evaluated by homeostatic model assessment (HOMA) method. 
Genotyping of β3-adrenergic receptor gene T↔C (Trp 64 Arg) was carried out by polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP). The DNA extracted from frozen blood by genomic 
DNA mini kit (Geneaid) (8). The DNA was amplified by PCR. A 255 bp DNA fragment containing the 
polymorphic site T↔C (Trp 64 Arg) of β3-adrenergic receptor gene was amplified by using specific primers 
(forward primer 5'-CCA GTG GGC TGC CAG GGG-3' and reverse primer 5'-GCC AGT GGC GCC CAA 
CGG-3') (9). PCR products were digested with MspI (Biolabs/England). The wild genotype (TT) remains uncut 
(255 bp) where as the homozygous genotype (CC) is digested into 158 and 97 bp fragments. The heterozygous 
genotype (TC) contained three bands sized 255, 158 and 97 bp. The restriction digestion products were analyzed 
on 2% agarose gel electrophoresis. 
 
2.3. Statistical Analysis 
The results of phenotypes data were expressed as mean ± SD. Student’s t-test  was used for the evaluation of 
data. Genotype data expressed as odds ratio (OR), confidence interval (CI) 95%. Statistical analyses were 
performed with SPSS  (version 20). P-value less than 0.05 was considered to be statistically significant.. 
 
3. Results 
Fasting glucose, insulin, HOMA and total cholesterol, TG, VLDL-cholesterol and LDL-cholesterol levels were 
found to be elevated significantly (p < 0.001) in type 2 diabetic patients when compared to those of the control 
group. However HDL-cholesterol was observed to be lowered significantly (p < 0.05) during comparable 
evaluation as shown in table 1. 
Results indicated that 92 (89%) out of 103 type 2 diabetic patients were insulin resistant when they 
were evaluated by the HOMA method. However 5 (9%) out of 57 healthy individuals were observed to be 
insulin resistant when they were analyzed similarly, hence these patients were excluded from the current 
investigation. 
The analysis of results indicated that the β3-adrenergic receptor gene T↔C (Trp 64 Arg) SNP 
genotype frequencies of wild genotype (TT) and heterozygous genotype (TC) were 80.43% and 19.57% in the 
insulin resistant type 2 diabetic patients and 94.23% and 5.77% in the control group respectively. The 
homozygous genotype (CC) were absent in insulin resistant type 2 diabetic patients and the control group as 
shown in table 2. The heterozygous genotype (TC) was significantly increase (OR=4.12, CI 95% 1.14-15.86, P < 
0.05) the risk of type 2 DM by four folds with respect to those of the wild genotype (TT) after adjustment for age, 
sex and BMI. No significant variations were obtained when the analysis was carried out without adjustment. 
The allele frequencies of T and C were 90.22% and 9.78% for the insulin resistant type 2 diabetic 
patients group and 97.12% and 2.88% for the control group respectively as shown in table 3. Finally, The results 
of present study reveal that significant increase (P < 0.05) in fasting insulin, HOMA, BMI and significant 
decrease (P < 0.05) in HDL-cholesterol of heterozygous genotype (TC) when compared with wild genotype (TT). 
Also there are no significant  differences in other clinical characteristics between wild genotype (TT) and 
heterozygous genotype (TC) as shown in table 4. 
 
4. Discussion 
β3-adrenergic receptor is an essential component of the sympathetic adrenoceptor signaling systems. β3-
adrenergic receptor is expressed in adipose tissues (white and brown adipose tissue). The receptor is activated 
during lipolysis in white adipose tissues, also it is activated during thermogenesis in brown adipose tissue. β3-
adrenergic receptor mediates catecholamine induce lipolysis and thermogenesis of adipose tissue, these 
processes are important for the regulation of energy expenditure and body weight (10, 11). β3-adrenergic 
receptor polymorphisms have been suggested to contribute in the pathogenesis of obesity (12). In particular, a 
Trp 64 Arg in the β3-adrenergic gene i.e. substitution of tryptophan to arginine (TGG↔CGG) in codon 64 (Trp 
64 Arg) (13). Trp 64 Arg polymorphism is located in the first intracellular loop of the β3-adrenergic receptor. 
This sit is thought to be important for binding of noradrenaline and G proteins with β3-adrenergic receptor in 
adipose cells (14). β3-adrenergic receptor polymorphism may lead to a decrease in thermogenesis and lipolysis 
in adipose tissue. Therefore, an impairment of β3-adrenergic receptor function may lead to obesity and insulin 
resistance through its effect on energy expenditure in adipose tissue (15). The current results are in consistence 
with the result of Siyan et al. (16) and Walston et al. (17) studies in which the β3-adrenergic receptor gene T↔C 
(Trp 64 Arg) SNP was found to be associated with type 2 DM. On the other hand it differ from those described 
by Oizumi et al. (18) who did not find an association between heterozygous genotype (TC) of β3-adrenergic 
receptor gene T↔C (Trp 64 Arg) SNP and type 2 DM. 
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The presence of C allele of β3-adrenergic receptor gene in this study show an association with obesity 
(BMI). It is well known that obesity is one of the most important risk factors for the development of insulin 
resistance and type 2 diabetes mellitus (19). The alteration in function of β3-adrenergic receptor may promote 
the development of obesity through enhance lipid accumulation in white adipose tissue and decrease biological 
energy expenditure from brown adipose tissue as a result of decrease lipolysis (20, 21). The result of present 
study agrees with the result of      Mirrakhimov et al. (22) who show the C allele of the β3-adrenergic receptor 
gene in the studied group has an association with obesity and decreased HDL-cholesterol level, also the result 
agrees with the result of Naoki et al. (23) and Luis et al. (24) who show an association of the C allele of β3-
adrenergic receptor gene with higher levels of  insulin and HOMA. 
 
5. Conclusions 
β3-adrenergic receptor gene T↔C (Trp 64 Arg) NSP are associated and involved in the pathogenesis of insulin 
resistant type 2 diabetes mellitus in Iraqi  patients. Insulin levels, insulin resistance and HDL-cholesterol are 
directed by the heterozygous genotype (TC) of the investigated patients. 
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Table 1: Mean Fasting Serum Glucose, insulin, HOMA and Lipid Profile Concentration in Type 2 Diabetic 
Patients and the Control Group 
Parameter  Subjects Mean ± SD Range P-value 
Glucose (mmol/L) Control 4.83 ± 0.68 3.2-5.9 < 0.001 
patient 9.94 ± 2.95 7.1-20.2 
Insulin (µIU/mL) Control 8.24 ± 2.98 1.56-15.27  
< 0.001 patient 15.82 ± 7.79 5.47-44.36 
HOMA 
 
Control 1.80 ± 0.68 0.33 - 3.37  
< 0.001 patient 7.12  ± 4.29 2.16 - 28.45 
Total Cholesterol 
(mmol/L) 
Control 4.20 ± 0.72 2.66-5.39  
< 0.001 Patient 5.04 ± 0.92 3.81-6.91 
HDL Cholesterol 
(mmol/L) 
Control 1.04 ± 0.26 0.58-1.79  
< 0.05 Patient 0.96 ± 0.22 0.52-1.54 
Triglycerides 
(mmol/L) 
Control 1.25 ± 0.52 0.49-2.27  
< 0.001 Patient 2.05 ± 0.94 0.56-3.97 
VLDL Cholesterol 
(mmol/L) 
Control 0.56±0.23 0.22-1.02  
< 0.001 Patient 0.92 ± 0.42 0.25-1.78 
LDL Cholesterol 
(mmol/L) 
Control 2.59 ± 0.77 1.16-4.19  
< 0.001 Patient 3.15 ± 1.01 1.15-5.39 
 
Table 2: Genotypes Distribution of β3-adrenergic Receptor Gene T↔C (Trp 64 Arg) SNP in Insulin Resistance 
Type 2 Diabetic Patients and Control Group  
Genotype Type 2 DM Control Unadjusted OR 
(95% CI) 
P-value 
Adjusted OR 
(95% CI) 
P-value 
TT No. 74 49 Reference Reference 
% 80.43% 94.23% 
TC 
 
No. 18 3 3.97 (1.11-14.21) 
P < 0.05 
4.12 (1.14-15.86) 
P < 0.05 % 19.57% 5.77% 
CC No. - -  
- 
 
- % - - 
Total No. 92 52 - - 
% 100% 100% 
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Table 3:  Allele Frequency of β3-adrenergic Receptor Gene T↔C (Trp 64 Arg) SNP in Insulin Resistance 
Type 2 Diabetic Patient and Control Group  
Allele Type 2 DM Control OR (95% CI) P-value 
 
T Allele 
No. 166 101  
Reference 
 
Reference % 90.22% 97.12% 
 
C Allele 
No. 18 3 3.65 
(1.04-12.7) 
 
< 0.01 % 9.78% 2.88% 
 
Total Allele 
No. 184 104  
- 
 
- % 100% 100% 
 
Table 4: Genotypes Correlation of β3-adrenergic Receptor Gene T↔C (Trp 64 Arg) SNP with Clinical 
Characteristics in Insulin Resistance Type 2 Diabetic Patient Group  
Clinical 
Characteristic 
Genotype Mean ± SD Range P 
value 
Glucose 
(mmol/L) 
TT 10.2 ± 3.00 7.2 - 18.6  
NS TC 10.1 ± 3.20 7.6 - 20.2 
Insulin 
(µIU/mL) 
TT 15.94 ± 6.58 7.1 - 36.21  
< 0.05 TC 20.85 ± 9.95 7.68 - 44.36 
 
HOMA 
TT 7.22 ± 3.55 2.51 - 26.36  
< 0.05 TC 9.58 ± 5.96 5.53 - 28.45 
Total Cholesterol 
(mmol/L) 
TT 5.10 ± 0.93 3.81 - 6.89  
NS TC 4.81 ± 0.92 3.81 - 6.91 
HDL Cholesterol 
(mmol/L) 
TT 0.96 ± 0.19 0.54 - 1.49  
< 0.05 TC 0.85 ± 0.23 0.52 - 1.44 
Triglycerides 
(mmol/L) 
TT 2.03 ± 0.91 0.56 - 3.97  
NS TC 1.94 ± 1.10 0.74 - 3.97 
VLDL Cholesterol 
(mmol/L) 
TT 0.91 ± 0.41 0.25 - 1.78  
NS TC 0.87 ± 0.49 0.33 - 1.78 
LDL Cholesterol 
(mmol/L) 
TT 3.22 ± 1.07 1.15 - 5.39  
NS TC 3.08 ± 0.92 1.50 - 5.13 
 
BMI 
TT 29.94 ± 3.09 23.87 - 37.29  
< 0.05 TC 31.46 ± 3.77 25.68 - 38.07 
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